Latest news
Injection molded ICOcap
The development of Iconovo's proprietary capsule based inhaler, ICOcap has reached an important milestone. The first mold tools have been manufactured…
Pulmonary Drug Delivery: Advances and Challenges
Orest Lastow is the co-author of a recently published book titled "Pulmonary Drug Delivery: Advances and Challenges". The book addresses problems associated…
Press releases
Feb 15, 2024, 20:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Feb 15, 2024, 19:35
News
IR
English
Regulatory
MAR
Report
Interim
Yearend
Feb 15, 2024, 19:35
News
IR
Swedish
Regulatory
MAR
Report
Interim
Yearend
Feb 15, 2024, 19:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
mfn-cus-top-disclaimer
Feb 15, 2024, 19:30
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
mfn-cus-top-disclaimer
Feb 07, 2024, 14:50
News
IR
Swedish
Regulatory
MAR
Corporate Action
Other
Feb 07, 2024, 14:50
News
IR
English
Regulatory
MAR
Corporate Action
Other
Feb 06, 2024, 14:45
News
IR
English
Corporate Action
Other
Feb 06, 2024, 14:45
News
IR
Swedish
Corporate Action
Other
Feb 01, 2024, 08:00
News
IR
Swedish
Regulatory
MAR
Corporate Action
Other
mfn-cus-disclaimer
Feb 01, 2024, 08:00
News
IR
English
Regulatory
MAR
Corporate Action
Other
mfn-cus-disclaimer
Jan 08, 2024, 09:00
News
IR
English
Corporate Action
Other
Jan 08, 2024, 09:00
News
IR
Swedish
Corporate Action
Other
Nov 30, 2023, 09:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Other
Nov 30, 2023, 09:30
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Other
Nov 29, 2023, 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Nov 29, 2023, 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Nov 16, 2023, 11:15
News
IR
English
Corporate Action
Other
Nov 16, 2023, 11:15
News
IR
Swedish
Corporate Action
Other
Oct 31, 2023, 08:30
News
IR
Swedish
Corporate Action
Other
mfn-cus-disclaimer
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
